119 related articles for article (PubMed ID: 3512737)
1. Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1.
Poindexter NJ; Schlievert PM
J Infect Dis; 1986 Apr; 153(4):772-9. PubMed ID: 3512737
[TBL] [Abstract][Full Text] [Related]
2. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
Hofer MF; Lester MR; Schlievert PM; Leung DY
Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
[TBL] [Abstract][Full Text] [Related]
4. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
[TBL] [Abstract][Full Text] [Related]
5. Binding of toxic-shock-syndrome toxin-1 to human peripheral blood mononuclear cells.
Poindexter NJ; Schlievert PM
J Infect Dis; 1987 Jul; 156(1):122-9. PubMed ID: 3598213
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigens.
Stohl W; Elliot JE
Clin Immunol Immunopathol; 1996 May; 79(2):122-33. PubMed ID: 8620618
[TBL] [Abstract][Full Text] [Related]
7. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.
Poindexter NJ; Schlievert PM
J Infect Dis; 1985 Jan; 151(1):65-72. PubMed ID: 3871225
[TBL] [Abstract][Full Text] [Related]
8. Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes.
Wood SC; Holsapple MP
Fundam Appl Toxicol; 1993 Apr; 20(3):280-7. PubMed ID: 8504901
[TBL] [Abstract][Full Text] [Related]
9. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Wakai M; Yoshioka M; Fujikawa H; Igarashi H
Microbiol Immunol; 1986; 30(5):469-83. PubMed ID: 3489157
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.
Hofer MF; Newell K; Duke RC; Schlievert PM; Freed JH; Leung DY
Proc Natl Acad Sci U S A; 1996 May; 93(11):5425-30. PubMed ID: 8643591
[TBL] [Abstract][Full Text] [Related]
11. Pokeweed mitogen activated suppressor T-cells preferentially reduce immunoglobulin secretion by differentiated B-lymphocytes.
Pryjma J; Flad HD; Ernst M; Pituch-Noworolska A
Immunol Lett; 1986 Oct; 13(5):273-9. PubMed ID: 2945779
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro.
Calvano SE; Quimby FW; Antonacci AC; Reiser RF; Bergdoll MS; Dineen P
Clin Immunol Immunopathol; 1984 Oct; 33(1):99-110. PubMed ID: 6332701
[TBL] [Abstract][Full Text] [Related]
13. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
14. The role of monocytes in pokeweed mitogen-stimulated human B cell activation: separate requirements for intact monocytes and a soluble monocyte factor.
Rosenberg SA; Lipsky PE
J Immunol; 1981 Apr; 126(4):1341-5. PubMed ID: 6782159
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
Fukushima H; Hirano T; Oka K
Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
[TBL] [Abstract][Full Text] [Related]
16. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
17. Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments.
Blomster-Hautamaa DA; Novick RP; Schlievert PM
J Immunol; 1986 Dec; 137(11):3572-6. PubMed ID: 3782792
[TBL] [Abstract][Full Text] [Related]
18. Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1.
Edwin C; Swack JA; Williams K; Bonventre PF; Kass EH
J Infect Dis; 1991 Mar; 163(3):524-9. PubMed ID: 1995725
[TBL] [Abstract][Full Text] [Related]
19. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.
Konno O; Hirano T; Katsuyama K; Oka K; Matsuno N; Nagao T
Transpl Immunol; 2007 Apr; 17(3):187-92. PubMed ID: 17331845
[TBL] [Abstract][Full Text] [Related]
20. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]